0
9 Meters Biopharma, Inc. Banner Image

9 Meters Biopharma, Inc. has reached its limit for free report views

Work for 9 Meters Biopharma, Inc.? Upgrade Your Profile and unlock all your annual reports.

9 Meters Biopharma, Inc.

  • Ticker NMTR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
9 Meters Biopharma, Inc. Logo Image
  • 1-10 Employees
  • Based in Raleigh, North Carolina
9 Meters Biopharma, Inc. ("the Company") is a rare and unmet needs-focused gastroenterology company. The Company is advancing NM-002, a proprietary long-acting GLP-1 agonist into a Phase 2 trial for Short Bowel Syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiacMore disease.
9 Meters Biopharma, Inc.

Most Recent Annual Report

9 Meters Biopharma, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. 9 Meters Biopharma, Inc. has reached its limit for free report views.

Older/Archived Annual Reports